Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease

Annals of Neurology

Volumn 72, Issue 2, 2012, Pages 278-285

  McGuire, Lynne I ^a   Peden, Alexander H ^a   Orrú, Christina D ^b   Wilham, Jason M ^b   Appleford, Nigel E ^c   Mallinson, Gary ^c   Andrews, Mary ^a   Head, Mark W ^a   Caughey, Byron ^b   Will, Robert G ^a   Knight, Richard S G ^a   Green, Alison J E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN TISSUE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; FEMALE; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRION; PRIORITY JOURNAL; PROTEIN DETERMINATION; REAL TIME QUAKING INDUCED CONVERSION; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEX RATIO; SPORADIC CREUTZFELDT JAKOB DISEASE;

14-3-3 PROTEINS; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BRAIN; COMPUTER SYSTEMS; CREUTZFELDT-JAKOB SYNDROME; CRICETINAE; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIONS; SENSITIVITY AND SPECIFICITY;

EID: 84865587647     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23589     Document Type: Article

References (20)

1. Report of a WHO consultation on global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies. Geneva, Switzerland: World Health Organization, 1998.
2. Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132: 2659-2668.
3. Sanchez-Juan P, Green A, Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006; 67: 637-643. (Pubitemid 44273611)
4. Collins S, Boyd A, Fletcher A, et al. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid. J Clin Neurosci 2000; 7: 203-208. (Pubitemid 30484976)
5. Shi Q, Gao C, Zhou W, et al. Surveillance for Creutzfeldt-Jakob disease in China from 2006-2007. BMC Public Health 2008; 8: 360.
6. Satoh K, Shirabe S, Eguchi H, et al. 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol 2006; 26: 45-52. (Pubitemid 43987368)
7. Geschwind MD, Martindale J, Miller D, et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2003; 60: 813-816. (Pubitemid 36705966)
8. Saa P, Castilla J, Soto C,. Presymptomatic detection of prions in blood. Science 2006; 313: 92-94. (Pubitemid 44051260)
9. Atarashi R, Wilham JM, Christensen L, et al. Simplified ultrasensitive detection of recombinant PrP conversion with shaking. Nat Methods 2008; 5: 211-212. (Pubitemid 351325633)
10. res detection using seeded conversion of recombinant prion protein. Protein Eng Des Sel 2009; 22: 515-521.
11. Wilham JM, Orru CD, Bessen RA, et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathogens 2010; 6: e1001217.
12. Atarashi R, Satoh K, Sano K, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking induced conversion. Nat Med 2011; 17: 175-178.
13. Gambetti P, Kong Q, Zou W, et al. Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003; 66: 213-239. (Pubitemid 37173504)
14. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 42: 224-233. (Pubitemid 29382879)
15. Chohan G, Pennington C, MacKenzie JM, et al. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 2010; 81: 1243-1248.
16. Hill A, Joiner S, Wadsworth JDF, et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 2003; 126: 1333-1346. (Pubitemid 36644379)
17. Nurmi MH, Bishop M, Strain L, et al. The normal population distribution of PRNP codon 129 polymorphism. Acta Neurol Scand 2003; 108: 374-378. (Pubitemid 37357644)
18. Zou W-Q, Puoti G, Xiao X, et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 2010; 68: 162-172.
19. Caughey B, Raymond GJ, Ernst D, Race RE,. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 1991; 65: 6597-6603.
20. Orrú CD, Wilham JM, Raymond LD, et al. Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2011; 2: e00078-11.